Linked Life Data

20838621

Source:http://linkedlifedata.com/resource/pubmed/id/20838621

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2010-9-14
pubmed:abstractText
Evaluation of cancer biomarkers from blood could significantly enable biomarker assessment by providing a relatively non-invasive source of representative tumor material. Circulating Tumor Cells (CTCs) isolated from blood of metastatic cancer patients hold significant promise in this regard.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1932-6203
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e12517
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Molecular biomarker analyses using circulating tumor cells.
pubmed:affiliation
Department of Oncology Biomarker Development, Genentech, Inc, South San Francisco, California, United States of America. punnoose.elizabeth@gene.com
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't